Scientific Opinion on the safety of trivalent chromium as a nutrient added for nutritional purposes to foodstuffs for particular nutritional uses and foods intended for the general population (including food supplements)
2010; Wiley; Volume: 8; Issue: 12 Linguagem: Inglês
10.2903/j.efsa.2010.1882
ISSN1831-4732
Tópico(s)Mercury impact and mitigation studies
ResumoEFSA JournalVolume 8, Issue 12 1882 OpinionOpen Access Scientific Opinion on the safety of trivalent chromium as a nutrient added for nutritional purposes to foodstuffs for particular nutritional uses and foods intended for the general population (including food supplements) EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS), EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS)Search for more papers by this author EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS), EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS)Search for more papers by this author First published: 01 December 2010 https://doi.org/10.2903/j.efsa.2010.1882Citations: 9 Panel members: F. Aguilar, B. Dusemund, P. Galtier, J. Gilbert, D.M. Gott, S. Grilli, R. Gürtler, J. König, C. Lambré, J-C. Larsen, J-C. Leblanc, A. Mortensen, D. Parent-Massin, I. Pratt, I.M.C.M. Rietjens, I. Stankovic, P. Tobback, T. Verguieva, R.A. Woutersen Correspondence: [email protected] Acknowledgement: The Panel wishes to thank the members of the Working Group B on Food Additives and Nutrient Sources added to Food: M. Bakker, D. Boskou, B. Dusemund, D. Gott, T. Hallas-Møller, A. Hearty, J. König, D. Marzin, D. Parent-Massin, I.M.C.M. Rietjens, G.J.A. Speijers, P. Tobback, T. Verguieva, R.A. Woutersen for the preparatory work on this scientific opinion. Adoption date: 10 November 2010 Published date: 1 December 2010 Question number: EFSA-Q-2009-00870 On request from: European Commission AboutPDF ToolsExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Abstract The Panel on Food Additives and Nutrient Sources added to Food delivers a scientific opinion re-evaluating the safety of chromium(III) as a nutrient added to foods for particular nutritional uses (PARNUTS) and foods intended for the general population (including food supplements). The Panel concluded that following oral administration, trivalent chromium is poorly absorbed. The results of in vitro bacterial mutagenicity assays have been consistently negative. The results of other genotoxicity studies are conflicting. The Panel also evaluated new in vitro and in vivo studies on the genotoxicity of chromium(III) compounds which were not covered by previous evaluations. The Panel concluded that in very large amounts, certain trivalent chromium compounds are cytotoxic and have been shown to cause chromosomal damage. The Panel also evaluated the data on long-term toxicity and carcinogenicity for chromium(III). Based on the facts i) that maximum intake levels of up to 250 µg/day for supplemental intake as suggested by the WHO would be in the same order of magnitude as the exposure resulting from normal dietary intake, ii) that in vitro, at high concentrations, chromium(III) might cause DNA damage, iii) that this DNA damage is not reflected in in vivo genotoxicity assays performed according to standard OECD protocols and in NTP studies, iv) that chromium(III) is not carcinogenic, v) that there is a large margin of safety of 4 to 5 orders of magnitude between a daily intake of 250 µg/day, equivalent to 4.1 µg/kg bw/day for a 60 kg person, and the NOAEL calculated for chromium(III) from the NOAEL for chromium(III) picolinate in the long-term NTP studies in mice and rats, the Panel concluded that the safety of chromium(III) as a nutrient added to PARNUTS and foods intended for the general population (including food supplements) is not of concern, provided that the intake of chromium(III) from these sources does not exceed 250 µg/day, the value established by the WHO for supplemental intake of chromium that should not be exceeded. References Abdulla M, Behbehani A and Dashti H, 1989. Dietary intake and bioavailability of trace elements. Biological Trace Element Research 21, 173– 178. Anderson RA and Kozlovsky AS, 1985. Chromium intake, absorption and excretion of subjects consuming self-selected diets. The American Journal of Clinical Nutrition 41, 1177– 1183. Anderson RA, Bryden NA, Polansky MM and Gautschi K, 1996. Dietary chromium effects on tissue chromium concentrations and chromium absorption in rats. The Journal of Trace Elements in Experimental Medicine 9, 11– 25. Anderson RA, Cheng N, Bryden NA, Polansky MM, Cheng N, Chi J and Feng J, 1997a. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type II diabetes. Diabetes 46, 1786– 1791. Anderson RA, Bryden NA and Polansky MM, 1997b. Lack of toxicity of chromium chloride and chromium(III) picolinate in rats. Journal of the American College of Nutrition 16, 273– 279. Anderson RA, Bryden NA and Polansky MM, 1997c. Lack of toxicity of chromium chloride and chromium picolinate in rats. Journal of the American College of Nutrition 16, 273– 279. Andersson MA, Petersson-Grawe KV, Karlsson OM, Abramsson-Zetterberg LAG and Hellman BE, 2007. Evaluation of the potential genotoxicity of chromium(III) picolinate in mammalian cells in vivo and in vitro. Food and Chemical Toxicology 45, 1097– 1106. ATSDR (Agency for Toxic Substances and Disease Registry), 2000. Toxicological Profile for Chromium. Centers for Disease Control and Prevention (CDC), Agency for Toxic Substances and Disease Registry (ATSDR), Atlanta, Georgia. Available from: www.atsdr.cdc.gov/toxprofiles/tp7.pdf. Bagchi D, Bagchi M, Balmoori J, Ye X and Stohs SJ, 1997. Comparative Induction of Oxidative Stress in Cultured J774A.1 Macrophage Cells by Chromium(III) picolinate and Chromium Nicotinate. Research Communications in Molecular Pathology and Pharmacology 97, 335– 346. Bailey MM, Boohaker J, Sawyer R, Behling J, Rasco J, Jernigan J, Hood R and Vincent J, 2006. Exposure of pregnant mice to chromium(III) picolinate results in skeletal defects in their offspring. Birth Defects Research (Part B) 77, 244– 249. Bailey MM, Sturdivant J, Jernigan PL, Townsend MB, Bushman J, Ankareddi I, Rasco JF, Hood RD and Vincent JB, 2008a. Comparison of the potential for developmental toxicity of prenatal exposure to two dietary chromium supplements, chromium(III) picolinate and [Cr3O(O2CCH2CH3)6(H2O)3]+, in mice. Birth Defects Research (Part B) 83, 27– 31. Bailey MM, Boohaker JG, Jernigan PL, Townsend MB, Sturdivant J, Rasco JF, Vincent JB and Hood RD, 2008b. Effects of pre- and postnatal exposure to chromium(III) picolinate or picolinic acid on neurological development in CD-1 mice. Biological Trace Elements Research 124, 79– 82. Barberá M, Farré R, Lozano A, 1989. Oral intake of cadmium, lead, cobalt, chromium, nickel, copper, manganese and zink in Spanish diet, estimated by a duplicate meal study. Journal of Micronutrient Analysis 6, 47– 57. Basketter DA, Angelini G, Ingber A, Kern PS and Menné T, 2003. Nickel, chromium and cobalt in consumer products: revisiting safe levels in the new millennium. Contact Dermatitis 49, 1– 7. Bataineh H, Al-Hamood MH, Elbetieha A and Bani Hani I, 1997. Effect of long-term ingestion of chromium compounds on aggression, sex behaviour and fertility in the adult male rat. Drug and Chemical Toxicology 20, 133– 149. BDL, 1995. Evaluation of Chromium(III) picolinate in the Ames/Salmonella Mutagenicity Assay. Prepared by Biodevelopment Laboratories, Inc. for Nutrition 21, San Diego, Calif.; [BDL Reference Number 30101]. Berner TO, Murphy MM and Slesinski R, 2004. Determining the safety of chromium tripicolinate for addition to foods as a nutrient supplement. Food and Chemical Toxicology 42, 1029– 1042. BfR (Federal Institute for Risk Assessment), 2004. Verwendung von Mineralstoffen in Lebensmitteln Toxikologische und ernährungsphysiologische Aspekte Teil II. Bundesinstitut für Risikobewertung (BfR)(Federal Institute for Risk Assessment), Berlin, Germany. Available from: www.bfr.bund.de/cm/238/verwendung_von_mineralstoffen_in_lebensmitteln_bfr_wissenschaft_4_2004.pdf. Bhagat J, Ahmed KA, Tyagi P, Saxena M and Saxena VK, 2008. Effects of supplemental chromium on interferon-gamma mRNA expression in response to Newcastle disease vaccine in broiler chicken. Research in Veterinary Sciences 85, 46– 51. Cefalu WT, Wang ZQ, Zhang XH, Baldor LC and Russell JC, 2002. Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats. Journal of Nutrition 132, 1107– 1114. Chang GX, Mallard BA, Mowat DN and Gallo GF, 1996. Effect of supplemental chromium on antibody response of newly arrived feeder calves to vaccines and ovalbumin. Canadian Journal of Veterinary Research 60, 140– 144. Clodfelder BJ, Emamaullee J, Hepburn DDD, Chakov NE, Nettles HS, Vincent JB, 2001 The trail of chromium(III) in vivo from the blood to the urine: the roles of transferring and chromodulin. Journal of Biological Inorganic Chemistry 6, 608– 617. Codex Alimentarius Commission, 1997. Codex Standard for Natural Mineral Waters. Codex Alimentarius Commission, Rome, Italy; [Codex Stan 108–1981 Rev 1–1997]. Available from: www.codexalimentarius.net/download/standards/223/CXS_108e.pdf. COM (Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment), 2004. Statement on the Mutagenicity of Trivalent Chromium and Chromium(III) picolinate. UK Department of Health. Committee on Mutagenicity (COM) [Committees on Toxicity, Mutagenicity, Carcinogenicity of Chemicals in Food, Consumer Products and the Environment], London, Engl.; [COM/04/S3]. Available from: www.advisorybodies.doh.gov.uk/com/chromium.htm. COMA (UK Committee on Medical Aspects of Food Policy), 1991. Chromium. In Dietary Reference Values for Energy and Nutrients for the United Kingdom. Report of the Dietary Reference Values of the Committee on Medical Aspects of Food Policy. UK Department of Health, Committee on Medical Aspects of Food Policy (COMA)/Her Majesty's Stationary Office (HMSO), London, Engl. Report on Health and Social Subjects No. 41, pp. 181– 182. Conn LW, Webster HL, Johnson AH, 1932. Chromium toxicology absorption of chromium by the rat when milk containing chromium was fed. American Journal of Hygiene 15, 760– 765. Coryell VH and Stearns DM, 2006. Molecular analysis of hprt mutations induced by chromium(III) picolinate in CHO AA8 cells. Mutation Research 610, 114– 23. D-A-CH Referenzwerte, 2000. Deutsche Gesellschaft für Ernährung, Österreichische Gesellschafter für Ernährung, Schweizerische Gesellschafter für Ernährungsforschung, Schweizerische Vereinigung für Ernährung: Referenzwerte für die Nährstoffzufuhr, Umschau/Braus Verlag. Eastmond DA, Macgregor JT and Slesinski RS, 2008. Trivalent Chromium: Assessing the genotoxic risk of an essential trace element and widely used human and Animal Nutritional supplement. Critical Reviews in Toxicology 38(3), 173– 190. EFSA (European Food Safety Authority), 2005. Opinion of the Scientific Committee on a request from EFSA related to a harmonised approach for risk assessment of substances which are both genotoxic and carcinogenic. The EFSA Journal 282, 1– 31. Available from: www.efsa.europa.eu/en/scdocs/doc/282.pdf. EFSA (European Food Safety Authority), 2008. EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS). Scientific opinion on the mixture of chromium di- and tri-nicotinate as a source of chromium added for nutritional purposes in food supplements and in foods for particular nutritional uses. Adopted on 26 November 2008. The EFSA Journal 887, 1– 24. Available from: www.efsa.europa.eu/en/scdocs/doc/887.pdf. EFSA (European Food Safety Authority), 2009a. EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS). Scientific opinion on Chromium(III) picolinate, zinc picolinate and zinc picolinate dihydrate added for nutritional purposes in food supplements. Adopted on 4 June 2009. The EFSA Journal 1113, 1– 41. Available from: www.efsa.europa.eu/en/scdocs/doc/1113.pdf. EFSA (European Food Safety Authority), 2009b. EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS). Scientific opinion on Chromium nitrate as a source of chromium added for nutritional purposes to food supplements. Adopted on 2 June 2009. The EFSA Journal 1111, 1– 19. Available from: www.efsa.europa.eu/en/scdocs/doc/1111.pdf. EFSA (European Food Safety Authority), 2009c. EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS). Scientific opinion on Chromium(III) lactate trihydrate as a source of chromium added for nutritional purposes to food supplements. Adopted on 2 June 2009. The EFSA Journal 1112, 1– 20. Available from: www.efsa.europa.eu/en/scdocs/doc/1112.pdf. EFSA (European Food Safety Authority), 2009d. Safety and efficacy of chromium methionine (Availa®Cr) as feed additive for all species. Scientific Opinion of the Panel on Additives and Products or Substances used in Animal Feed (Question No EFSA-Q-2006-066). Adopted on 1 April 2009. The EFSA Journal 1043, 1– 53. EFSA (European Food Safety Authority), 2010. Scientific Opinion on the safety of chromium picolinate as a source of chromium added for nutritional purposes to foodstuff for particular nutritional uses and to foods intended for the general population). Scientific Opinion of the Panel on Food Additives and Nutrient Sources added to Food (Question N$ EFSA-Q-2009-00763). Adopted on 10 November 2010. The EFSA Journal 1883, 8(11). Elbetieha A and Al-Hamood MH, 1997. Long-term exposure of male and female mice to trivalent and hexavalent chromium compounds: effect on fertility. Toxicology 116, 39– 47. EPA US (Environmental Protection Agency), 1998. Toxicological Review of Trivalent Chromium (CAS No. 16065-83-1). National Center for Environmental Assessment, Office of Research and Development, Washington DC. www.epa.gov/NCEA/iris/toxreviews/0028tr.pdf. Esber H, Moreno V and Loveday KS, 1997. Evaluation of chromium(III) picolinate in the Ames and the rat in vivo of chromosomal aberration assays. Mutation Research 379, S89 [Abstract No. PXII.15]. EVM (Expert Group on Vitamins and Minerals), 2002. Review of chromium. Paper for discussion prepared by the UK Department of Health and MAFF, EVM/99/26, revised August 2002, London. www.food.gov.uk/multimedia/pdfs/reviewofchrome.pdf#page=1. EVM (Expert Group on Vitamins and Minerals), 2003. Risk assessment: Chromium. In: Safe Upper Levels for Vitamins and Minerals. Report on the Expert Group on Vitamins and Minerals (EVM). U.K. Food Standards Agency (FSA), Committee on Nutrition (SACN), Expert Group on Vitamins and Minerals (EVM), London, Engl.; pp. 172– 179. Available from: www.food.gov.uk/multimedia/pdfs/vitmin2003.pdf. Friedman J, Shabtai F, Levy LS and Djaldetti M, 1987. Chromium chloride induces chromosomal aberrations in human lymphocytes via indirect action. Mutation Research 191, 207– 210. FNB (Food and Nutrition Board), 2001. Dietary Reference Intakes: Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium and Zinc. Washington D.C. FSA (UK Food Standard Agency), 2004. Agency Revises Chromium(III) picolinate Advice. Food Standards Agency (FSA), London, Engl.; [Press release issued December 13, 2004]. Available from: www.food.gov.uk/news/newsarchive/2004/dec/chromiumupdate. FSA (UK Food Standard Agency), 2008. Chromium. Food Standards Agency (FSA). Eat Well, Be Well-Helping You Make Heathier Choices, London, Engl. Available from: www.eatwell.gov.uk/healthydiet/nutritionessentials/vitaminsandminerals/chromium/?lang=gn. Gammelgaard B, Jensen K and Steffansen B, 1999. In vitro metabolism and permeation studies in rat jejunum: Organic chromium compared to inorganic chromium. Journal of Trace Elements in Medicine and Biology 13, 82– 88. Garcia E, Cabrera C, Lorenzo ML, Sánchez J and López MC, 2001. Daily dietary intake of chromium in southern Spain measured with duplicate diet sampling. The British Journal of Nutrition 86, 391– 6. Cited in: SCF, 2003b. Gargas ML, Norton RL, Paustenbach D and, Finley BL, 1994. Urinary excretion of chromium by humans following ingestion of chromium(III) picolinate. Implications for biomonitoring. Drug Metabolism and Disposition 22, 522– 529. Greenberg D, Komorowski JR and Loveday KJ, 1999. Rat chromosomes are unharmed by orally administered chromium(III) picolinate. Journal of the American College of Nutrition 18, 27. Gudi R, Slesinski RS, Clarke JJ and San RH, 2005. Chromium(III) picolinate does not produce chromosome damage in CHO cells. Mutation Research 587, 140– 146. Hagen CD, Lindemann MD and Purser KW, 2000. Effect of dietary chromium tripicolinate on productivity of sows under commercial conditions. Swine Health and Production 8, 59– 63. Hamamy HA, Al-Hakkak, ZS and Hussain AF, 1987. Chromosome aberrations in workers at a tannery in Iraq. Mutation Research 189, 395– 398. Hansen MB, Johansen JD and Menna T, 2003. Chromium allergy significance of both Cr(III) and Cr(VI) Contact Dermatitis 49(4), 206– 12. Hansen MB, Menne T, Johansen JD, 2006. Cr(III) and Cr(VI) in leather and elicitation of eczema. Contact Dermatitis, Volume 54, Issue 5, 278– 282. Hepburn DDD and Vincent JB, 2002. In vivo distribution of chromium from chromium(III) picolinate in rats and implications for the safety of the dietary supplement. Chemical Research in Toxicology 15, 93– 100. Hepburn DDD, Xiao J, Bindom S, Vincent JB and O'Donnell J, 2003a. Nutritional supplement chromium(III) picolinate causes sterility and lethal mutations in Drosophila melanogaster. Proceedings of the National Academy of Sciences USA 100, 3766– 3771. Hepburn DDD, Burney JM Woski SA and Vincent JB, 2003b. The nutritional supplement chromium(III) picolinate generates oxidative DNA damage and peroxidized lipids in vivo. Polyhedron 22, 455– 463. Hininger I, Benaraba R, Osman M, Faure H, Roussel A-M and Anderson RA, 2007. Safety of trivalent chromium complexes: No evidence for DNA damage in human HaCaT keratinocytes. Free Radical Biology and Medicine 42, 1759– 1765. IARC (International Agency for Research on Cancer), 1980. Chromium and chromium compounds. In: Some Metals and Metallic Compounds, Lyon (France), 205– 323. IARC (International Agency for Research on Cancer), 1990. Chromium, nickel and welding. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 49. IARC Scientific Publications, IARC, Lyon. IARC (International Agency for Research on Cancer), 1990. Chromium and chromium compounds. In Chromium, Nickel and Welding. IARC Working Group. June 5–13, 1989, Lyon, France. World Health Organization (WHO), International Agency for Research on Cancer (IARC), Lyon, France. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 49, 49– 256. Available from: monographs.iarc.fr/ENG/Monographs/vol49/volume49.pdf. IOM (Institute of Medicine), 2001 Chromium. In: Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium and Zinc. Panel on Micronutrients, Subcommittees on Upper Reference Levels of Nutrients and of Interpretation and Use of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine (IOM). National Academy Press (NAP), Washington, DC; pp. 197– 223. Available from: books.nap.edu/openbook.php?record_id=10026&page=197. IPCS (International Programme on Chemical Safety), 1988. Chromium. Environmental Health Criteria 61). World Health Organisation. Geneva. Ivankovic S and Preussmann R, 1975. Absence of toxic and carcinogenic effects after administration of high doses of chromic oxide pigment in subacute and long-term feeding experiments in rats. Food and Cosmetics Toxicology 13, 347– 351. Jana M, Rajaram A et al., 2009. "Chromium(III) picolinate induced apoptosis of lymphocytes and the signalling mechanisms thereof." Toxicology and Applied Pharmacology 237(3), 331– 44. Jeejeebhoy KN, 1999. The role of chromium in nutrition and therapeutics and as a potential toxin. Nutrition Reviews 57, 329– 335. Juturu V and Komorowski JR, 2002. Antimutagenic activity of chromium(III) picolinate in the Salmonella assay. Pharmacologist Supplement 44, A59 [Abstract No. 38.2]. Juturu V, Siesinshi RS, Gudi R, San R and Komorowshi JR, 2004. Chromium(III) picolinate does not produce chromosome damage in the in vitro mammalian chromosome abberation test with CHO cells. Environmental and Molecular Mutagenesis 44, 208 [Abstract No. 87]. Kim DS, Kim TW, Park IK, Kang JS and Om AS, 2002. Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body weight in dexamethasone-treated rats. Metabolism 51, 589– 594. Kim DS, Kim TW and Kang JS, 2004. Chromium picolinate supplementation improves insulin sensitivity in Goto-Kakzaki diabetic rats. Journal of Trace Elements in Medicine and Biology 17, 243– 247. Kiopes L, 1999. Evaluation of Chromium(III) picolinate in the Rat in Vivo Chromosomal Aberration Assay. Prepared by Primedica Corporation, Mass. for AMBI Inc., Purchase, New York; [Reference Number 30102]. Kirpnick-Sobol Z, Reliene R and Schiestl RH, 2006. Carcinogenic Cr(VI) and the Nutritional Supplement Cr(III) Induce DNA Deletions in Yeast and Mice. Cancer Research 66, 3480– 3484. Komorowski JR, Greenberg D and Juturu V, 2008. Chromium(III) picolinate does not produce chromosome damage. Toxicology in vitro 22, 819– 826. Kumpulainen JT, 1992, Chromium content of foods and diets. Biological Trace Element Research 32, 9– 18. Leblanc JC, 2004. The first French Total Diet Study – Mycotoxins, minerals and trace elements. INRA and Ministère de l'agriculture de l'alimentation de la pêche et des affaires rurales, Paris. Léonard A and Lauwerys RR, 1980. Carcinogenicity and mutagenicity of chromium. Mutation Research 76, 227– 239. Levina A and Lay P, 2008. Chemical properties and toxicity of chromium(III) nutritional supplements. Chemical Research in Toxicology 21, 563– 571. Levis AG, Bianchi V, Tamino G and Pegoraro B, 1978. Cytotoxic Effects of Hexavalent and Trivalent Chromium On Mammalian Cells In Vitro. British Journal of Cancer 37, 387– 396. Lindemann MD, Wood CM, Harper AF, Kornegay ET and Anderson RA, 1995. Dietary chromium(III) picolinate additions improve gain:feed and carcass characteristics in growing-finishing pigs and increase litter size in reproducing sows. Journal of Animal Science 73, 457– 465. Lindemann MD, Carter SD, Chiba LI, Dove CR, LeMieux FM and Southern LL, 2004. A regional evaluation of chromium tripicolinate supplementation of diets fed to reproducing sows. Journal of Animal Science 82, 2972– 2977. MacKenzie RD, Byerrum RU, Decker CF, Hoppert CA and Langham RF, 1958. Chronic toxicity studies: II. hexavalent and trivalent chromium administered in drinking water to rats. A.M.A. Archives of Industrial Health 18, 232– 234. A Martin (Guest ed.-in-chief), 2001. Micronutrients. 1.12. Chromium. In: Nutritional Recommendations for the French Population: The "Apports Nutritionnels Conseillés" (ANCs) (English condensed ed.). Lavoisier, Paris. Sciences des Aliments Sciences des Aliments 21, 4, 391– 392. Miller-Ihli NJ, Graphite Furnace Atomic Absorption Spectrometry for the Determination of the Chromium Content of Selected U.S. Foods, 1996. J. Food Comp. Anal. 9, 290– 300. Norseth T, 1981. The Carcinogenicity of Chromium. Environmental Health Perspectives 40, 121– 130. NTP (US National Toxicology Programme), 1999. Combined Summary Report (1500). Frequency of Micronuclei in Erythrocytes Following Administration of Chromium(III) picolinate Monohydrate by GAV (a). Department of Health and Human Services (DHHS). National Toxicology Program (NTP), Research Triangle Park, North Carolina. Unpublished Report. Cited In: NTP, 2009. NTP (US National Toxicology Programme), 2008. NTP Technical Report on the Toxicology and Carcinogenesis Studies of Chromium(III) picolinate Monohydrate (CAS No. 27882-76-4) in F344/N Rats and B6C3F1 Mice (Feed Studies): DRAFT. Department of Health and Human Services (DHHS). National Toxicology Program (NTP), Research Triangle Park, North Carolina. NTP Technical Report Series, No. 556. Abstract available from: ntp.niehs.nih.gov/index.cfm?objectid=6A4A18CB-F1F6-975E-72D4856D552E4068. Full Draft available from: http://ntp.niehs.nih.gov/files/TR556board_webRev.pdf. NTP. Testing Status: Chromium(III) picolinate Monohydrate M010098: CASRN: 27882-76-4. National Toxicology Program (NTP), Research Triangle Park, North Carolina; 2009. Available from: ntp.niehs.nih.gov/go/TS-M010098. OECD (Organisation for Economic Co-operation and Development), 1997. OECD Guidelines for the Testing of Chemicals, Section 4: Health Effects. Test No. 475: Mammalian Bone Marrow Chromosome Aberration Test. Adopted on 21 July 1997. Olin KL, Stearns DM, Armstrong WH and Keen CL, 1994. Comparative retention/absorption of 51chromium (51Cr) from 51Cr chloride, 51Cr nicotinate and 51Cr picolinate in a rat model. Trace Elements and Electrolytes 11, 182– 186. Pechova A, Cech S, Pavlata L and Podhorsky, 2003. The influence of chromium supplementation on metabolism, performance and reproduction of dairy cows in a herd with increased occurrence of ketosis. Czech Journal of Animal Science, 48, 348– 358. Polansky MM, Bryden NA, Anderson RA, 1993. Effects of Form of Chromium on Chromium Absorption. FASEB J. 7, abstract no 442. Preuss HG, Montamarry S, Echard B, Scheckenbach R and Bagchi D, 2001. Long-term effects of chromium, grape seed extract, and zinc on various metabolic parameters of rats. Molecular and Cellular Biochemistry 223, 95– 102. Sahin N and Sahin K, 2001. Optimal dietary concentrations of vitamin C and chromium(III) picolinate for alleviating the effect of low ambient temperature (6.2 °C) on egg production, some egg characteristics, and nutrient digestibility in laying hens. Veterinární Medícina 46, 229– 236. Sahin K, Küçük O, Sahin N and Ozbey, 2001. Effects of dietary chromium supplementation on egg production, egg quality and serum concentrations of insulin, corticosterone, and some metabolites of Japanese quails. Nutrition Research 21, 1315– 1321. Sahin K, Ozbey O, Onderci M, Cikim G and Aysondu MH, 2002a. Chromium supplementation can alleviate negative effects of heat stress on egg production, egg quality and some serum metabolites of laying Japanese quail. Journal of Nutrition 132, 1265– 1268. Sahin K, Sahin N and Kucuk O, 2002b. Effects of dietary chromium and ascorbic acid supplementation on digestion of nutrients, serum antioxidant status, and mineral concentrations in laying hens reared at low ambient temperature. Biological Trace Element Research 87, 113– 124. SCF (Scientific Committee on Food), 1993. Chromium (Chapter 32). In: Nutrient and Energy Intakes for the European Community (Opinion Expressed on 11 December, 1992). Commission of the European Communities (EEC), Scientific Committee for Food (SCF), Brussels, Belgium. Reports of the Scientific Committee for Food, 31st Series, pp. 218– 219. Available from: www.europa.eu.int/comm/food/fs/sc/scf/reports/scf_reports_31.pdf. SCF (Scientific Committee on Food), 2003a. Opinion of the Scientific Committee on Food on the Revision of Reference Values for Nutrition Labelling (Opinion expressed on 5 March 2003). European Commission, Health and Consumer Protection Directorate-General, Directorate C -Scientific Opinions, C2 - Management of Scientific Committees II; Scientific Co-operation and Networks, Scientific Committee on Food (SCF), Brussels, Belgium. [SCF/CS/NUT/GEN/18 Final]. Available from: ec.europa.eu/food/fs/sc/scf/out171_en.pdf. SCF (Scientific Committee on Food), 2003b. Opinion of the Scientific Committee on Food on the Tolerable Upper Intake Level of Trivalent Chromium (expressed in 4 April 2003). European Commission, Health and Consumer Protection Directorate-General, Directorate C - Scientific Opinions, C2 - Management of Scientific Committees II; Scientific Co-operation and Networks, Scientific Committee on Food (SCF), Brussels, Belgium. [SCF/CS/NUT/UPPLEV/67 Final]. Available from: ec.europa.eu/food/fs/sc/scf/out197_en.pdf. Schroeder HA, Balassa JJ and Vinton WH Jr., 1964. Chromium, lead, cadmium, nickel and titanium in mice: Effect on mortality, tumors and tissue levels. Journal of Nutrition 83, 239– 250. Schroeder HA, Balassa JJ and Vinton WH Jr., 1965. Chromium, cadmium and lead in rats: Effects on lifespan, tumors and tissue levels. Journal of Nutrition 86, 51– 66. Sharma AD, 2009. Low chromate diet in dermatology. Indian Journal of Dermatology 54(3), 293– 295. Schena D, Fantuzzi F and Girolomoni G, 2008. Contact allergy in chronic eczematous lip dermatitis. European Journal of Dermatology 18 (6), 688– 692. Shinde UA and Goyal RK, 2003. Effect of chromium picolinate on histopathological alterations in STZ and neonatal STZ diabetic rats. Journal of Cellular and Molecular Medicine 7, 322– 329. Shrivastava R, Upreti RK, Seth PK and Chaturvedi UC. 2002. Effects of chromium on the immune system. FEMS Immunology and Medical Microbiology 6, 34(1), 1– 7. Slesinski RS, San R, Clarke J, Juturu V and Komorowski JR, 2004. Lack of mutagenicity of chromium(III) picolinate in the cho/hgprt mutation assay: results from standard tests and a test with 48-hour exposure. Environmental and Molecular Mutagenesis 44, 227 [Abstract No. 163]. Smyth HF, Carptenter CP Jr, Weil CS, Pozzani UC, Striegel JA and Nycum JS, 1969. Range-finding toxicity data: List VII. American Industrial Hygiene Association JournalL 30, 470– 476. Speetjens JK, Collins RA, Vincent JB and Woski SA, 1999. The nutritional supplement chromium(III) tris(picolinate) cleaves DNA. Chemical Research in Toxicology 12, 483– 287. Stallings DM, Hepburn DDD, Hannah M, Vincent JB and O'Donnel J, 2006. Nutritional supplement chromium(III) picolinate generates chromosomal aberrations and impedes progeny development in Drosophila melanogaster. Mutation Research 610, 101– 113. Stearns DM, Wise JP, Patierno SR and Wetterhahn KE, 1995. Chromium(III) picolinate produces chromosome damage in Chinese hamster ovary cells. FASEB JournalL 9, 1643– 1648. Stearns DM, Silveira SM, Wolf KK and Luke AM, 2002. Chromium(III) tris(picolinate) is mutagenic at the hypoxanthine (guanine) phosphoribosyltransferase locus in Chinese hamster ovary cells. Mutation Research 513, 135– 142. Stohs SJ and Bagchi D, 1995. Oxidative Mechanisms In The Toxicity of Metal Ions. Free Radical Biology and Medicine 18, 321– 336. Stout MD, Nyska A, Collins BJ, Witt KL, Kissling GE, Malarkey DE and Hooth MJ, 2009. Chronic toxicity and carcinogenicity studies of chromium(III) picolinate monohydrate administered in feed to F344/N rats and B6C3F1 mice for 2 years. Food and Chemical Toxicology 47, 729– 733. Sun Y, Ramirez J, Woski SA and Vincent JB, 2000. The binding of trivalent chromium to low-molecular-weight chromium-binding substance (LMWCr) and the transfer of chromium from transferring and chromium(III) picolinate to LMWCr. Journal of Biological Inorganic Chemistry: JBIC 5, 129– 136. Tan GY, Zheng SS, Zhang MH, Feng JH, Xie P and Bi JM, 2008. Study of oxidative damage in growing-finishing pigs with continuous excess dietary chromium(III) picolinate intake. Biological Trace Elements Research 126, 129– 40. Tandon SK, Behari JR and Kachru DN, 1979. Distribution of chromium in poisoned rats. Toxicology, 18, 29– 34. Thyssen JP and Menné T, 2010. Metal allergy a review on exposures, penetration, genetics, prevalence, and clinical implications. Chemical Research in Toxicology 23 (2), 309– 318. US DHHS (United States Department of Health and Human Services), 2003. The Third National Health and Nutrition Examination Survey (NHANES) 1988–1994 (NHANES III). Centre for Disease Control and Prevention (CDC), National Centre for Health Statistics (NCHS), Hyattsville, Maryland. Cited in: SCF, 2003b. Information available from: www.cdc.gov/nchs/about/major/nhanes/nh3data.htm. US Patent 5.194.615. Synthetic GTF Chromium Nicotinate Material and its Preparation, March 16, 1993. Uusitupa MI, Mykkänen L, Siitonen O, Laakso M, Sarlund H, Kolehmainen P, Räsänen T, Kumpulainen J, Pyörälä K, 1992. Chromium supplementation in impaired glucose tolerance of elderly: effects on blood glucose, plasma insulin, C-peptide and lipid levels. Brit. J. Nutr. 68(1), 209– 16. Van Hoogstraten IMW, von Blomberg BME, Boden D, Kraal G and Scheper RJ, 1991. Effects of oral exposure to nickel or chromium on cutaneous sensitization. Current Problems in Dermatology 20, 237– 241. Veien NK, Hattel T and Laurberg G, 1994. Chromate-allergic patients challenged orally with potassium dichromate. Contact Dermatitis 31, 137– 9. Vernot EH, MacEwen JD, Haun CC and Kinkead ER, 1977. Acute toxicity and skin corrosion data for some organic and inorganic compounds and aqueous solutions. Toxicology and Applied Pharmacology 42, 417– 423. Vincent JB, 2000a. The biochemistry of chromium. Journal of Nutrition 130, 715– 718. Vincent JB, 2000b. Quest for the molecular mechanism of chromium action and its relationship to diabetes. Nutrition Reviews 58, 67– 72. Wang BJ, Sheu HM, Guo YL, Lee YH, Lai CS, Pan MH and Wang YJ, 2010. N-acetyl cysteine inhibits chromium hypersensitivity in co-adjuvant chromium-sensitized albino guinea pigs by suppressing the effects of reactive oxygen species. Experimental Dermatology, Volume 19, Issue 8, pages e191– e200, August 2010. WHO (World Health Organisation), 1996. Trace elements in human nutrition and health (A report of a re-evaluation of the role of trace elements in human health and nutrition). Geneva. Whittaker P, San RH, Clarke JJ, Seifried HE and Dunkel VC, 2005. Mutagenicity of chromium(III) picolinate and its components in Salmonella typhimurium and L5178Y mouse lymphoma cells. Food and Chemical Toxicology 43, 1619– 1625. Zhang M, Chen Z, Chen Q, Zou H, Lou J and He J, 2008. Investigating DNA damage in tannery workers occupationally exposed to trivalent chromium using comet assay. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 654, 45– 51. Citing Literature Volume8, Issue12December 20101882 ReferencesRelatedInformation
Referência(s)